Michael Rainer

1.2k total citations
38 papers, 664 citations indexed

About

Michael Rainer is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, Michael Rainer has authored 38 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in Michael Rainer's work include Dementia and Cognitive Impairment Research (11 papers), Alzheimer's disease research and treatments (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Michael Rainer is often cited by papers focused on Dementia and Cognitive Impairment Research (11 papers), Alzheimer's disease research and treatments (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Michael Rainer collaborates with scholars based in Austria, Germany and Switzerland. Michael Rainer's co-authors include Peter Fischer, Susanne Jungwirth, Karl‐Heinz Tragl, Sonja Zehetmayer, Hermann AM Mucke, Silvia Weissgram, Peter Dal‐Bianco, Ildiko Wichart, Edna Grünblatt and W Danielczyk and has published in prestigious journals such as The British Journal of Psychiatry, Psychopharmacology and The Journal of Clinical Psychiatry.

In The Last Decade

Michael Rainer

36 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Rainer Austria 15 218 198 140 86 83 38 664
Hyun Jeong Han South Korea 16 211 1.0× 243 1.2× 119 0.8× 56 0.7× 85 1.0× 51 595
Geetha Ramaswamy United States 3 262 1.2× 207 1.0× 91 0.7× 126 1.5× 74 0.9× 6 636
Haruko Tanji Japan 12 288 1.3× 279 1.4× 68 0.5× 127 1.5× 107 1.3× 19 766
Simon Vann Jones United Kingdom 6 198 0.9× 207 1.0× 68 0.5× 61 0.7× 91 1.1× 9 611
Zein Al-Atrache United States 6 370 1.7× 196 1.0× 81 0.6× 199 2.3× 137 1.7× 12 852
Tiago Coimbra Costa Pinto Brazil 13 140 0.6× 218 1.1× 61 0.4× 84 1.0× 71 0.9× 21 746
Raymond Levy United Kingdom 11 275 1.3× 395 2.0× 126 0.9× 83 1.0× 99 1.2× 23 742
John Culberson United States 14 233 1.1× 90 0.5× 90 0.6× 209 2.4× 90 1.1× 28 836
Marcos Vinícius Ferreira Silva Brazil 9 293 1.3× 124 0.6× 79 0.6× 173 2.0× 113 1.4× 20 747
S. Knox United Kingdom 11 193 0.9× 252 1.3× 62 0.4× 93 1.1× 83 1.0× 12 582

Countries citing papers authored by Michael Rainer

Since Specialization
Citations

This map shows the geographic impact of Michael Rainer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rainer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rainer more than expected).

Fields of papers citing papers by Michael Rainer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rainer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rainer. The network helps show where Michael Rainer may publish in the future.

Co-authorship network of co-authors of Michael Rainer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rainer. A scholar is included among the top collaborators of Michael Rainer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rainer. Michael Rainer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gatterer, Hannes, Günther Bernatzky, Johannes Burtscher, et al.. (2019). Are Pre-Ascent Low-Altitude Saliva Cortisol Levels Related to the Subsequent Acute Mountain Sickness Score? Observations from a Field Study. High Altitude Medicine & Biology. 20(4). 337–343. 9 indexed citations
2.
Kristoferitsch, Wolfgang, Julia Jecel, Helmut Rauschka, et al.. (2018). Secondary dementia due to Lyme neuroborreliosis. Wiener klinische Wochenschrift. 130(15-16). 468–478. 21 indexed citations
3.
Walker, Zuzana, Emilio Moreno, Alan Thomas, et al.. (2014). Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: Randomised study. The British Journal of Psychiatry. 206(2). 145–152. 40 indexed citations
4.
Rainer, Michael, Hermann AM Mucke, & Sandra Schlaefke. (2013). Ginkgo biloba extract EGb 761® in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting. Wiener klinische Wochenschrift. 125(1-2). 8–15. 15 indexed citations
5.
Mossaheb, Nilufar, Sonja Zehetmayer, Susanne Jungwirth, et al.. (2012). Are Specific Symptoms of Depression Predictive of Alzheimer’s Dementia?. The Journal of Clinical Psychiatry. 73(7). 1009–1015. 20 indexed citations
6.
Rainer, Michael, et al.. (2011). [Memory clinics in Austria - characteristics and patterns of practice].. PubMed. 25(1). 9–15. 2 indexed citations
7.
Schulz, Jörg B., Michael Rainer, Hans‐Hermann Klünemann, et al.. (2011). Sustained Effects of Once-Daily Memantine Treatment on Cognition and Functional Communication Skills in Patients with Moderate to Severe Alzheimer's Disease: Results of a 16-Week Open-Label Trial. Journal of Alzheimer s Disease. 25(3). 463–475. 27 indexed citations
8.
Bartl, Jasmin, Claus Jürgen Scholz, Susanne Jungwirth, et al.. (2011). Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzymegene. BMC Medical Genetics. 12(1). 151–151. 8 indexed citations
9.
Grünblatt, Edna, Andreas Reif, Susanne Jungwirth, et al.. (2011). Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer’s disease: The VITA and Milano studies. Journal of Psychiatric Research. 45(9). 1250–1256. 14 indexed citations
10.
Rainer, Michael, et al.. (2011). Memantine in moderate to severe Alzheimer’s disease: an observational post-marketing study. Journal of Neural Transmission. 118(8). 1255–1259. 11 indexed citations
11.
Schmidt, Reinhold, Ulf Baumhackl, Klaus Berek, et al.. (2010). [Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria].. PubMed. 24(2). 125–31. 5 indexed citations
12.
Mossaheb, Nilufar, Silvia Weissgram, Sonja Zehetmayer, et al.. (2009). Late-Onset Depression in Elderly Subjects From the Vienna Transdanube Aging (VITA) Study. The Journal of Clinical Psychiatry. 70(4). 500–508. 24 indexed citations
13.
Grünblatt, Edna, Sonja Zehetmayer, Jasmin Bartl, et al.. (2008). Genetic risk factors and markers for Alzheimer’s disease and/or depression in the VITA study. Journal of Psychiatric Research. 43(3). 298–308. 44 indexed citations
14.
Rainer, Michael. (2008). Risperidone long-acting injection: a review of its long term safety and efficacy. Neuropsychiatric Disease and Treatment. 4(5). 919–919. 49 indexed citations
15.
Fischer, Peter, Sonja Zehetmayer, Susanne Jungwirth, et al.. (2008). Risk Factors for Alzheimer Dementia in a Community-Based Birth Cohort at the Age of 75 Years. Dementia and Geriatric Cognitive Disorders. 25(6). 501–507. 38 indexed citations
16.
Rainer, Michael, Hermann AM Mucke, Sonja Zehetmayer, et al.. (2006). Data From the VITA Study Do Not Support the Concept of Vascular Depression. American Journal of Geriatric Psychiatry. 14(6). 531–537. 28 indexed citations
17.
Rainer, Michael, et al.. (2003). The Psychogeriatric Patient – a New Indication for Psychotherapy?. Wiener Medizinische Wochenschrift. 153(23-24). 506–511. 3 indexed citations
18.
Rainer, Michael, et al.. (2001). Effect of Risperidone on Behavioral and Psychological Symptoms and Cognitive Function in Dementia. The Journal of Clinical Psychiatry. 62(11). 894–900. 34 indexed citations
19.
Rainer, Michael & Hermann AM Mucke. (1998). Twenty years of cholinergic intervention in Alzheimer's disease: A tale of disappointment and ultimate confidence. International Journal of Psychiatry in Clinical Practice. 2(3). 173–179. 4 indexed citations
20.
Rainer, Michael. (1997). Galanthamine in Alzheimer??s Disease. CNS Drugs. 7(2). 89–97. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyun Jeong Han Breakdown of academic impact, for papers by Geetha Ramaswamy Breakdown of academic impact, for papers by Haruko Tanji Breakdown of academic impact, for papers by Simon Vann Jones Breakdown of academic impact, for papers by Zein Al-Atrache Breakdown of academic impact, for papers by Tiago Coimbra Costa Pinto Breakdown of academic impact, for papers by Raymond Levy Breakdown of academic impact, for papers by John Culberson Breakdown of academic impact, for papers by Marcos Vinícius Ferreira Silva Breakdown of academic impact, for papers by S. Knox
Rankless by CCL
2026